GALECTIN THERAPEUTICS INC (GALT) Institutional Ownership and Insiders Activity
GALECTIN THERAPEUTICS INC (GALT) is widely held by institutional investors, with 95 firms reporting positions valued at approximately $70.76M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $13.87M in GALT holdings in its latest filing.
Recent insider activity includes 3 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
95
Total Reported Value
$70.76M
Largest Holder
Blackrock, Inc.
Largest Position
$13.87M
Insider Transactions (90d)
3
Latest Filing Quarter
Q2 2026
New Institutional Positions
20
Funds Exiting Positions
24
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$13.87M
- Vanguard Capital Management Llc$10.06M
- Geode Capital Management, Llc$6.07M
- Osaic Holdings, Inc.$5.59M
- Marshall Wace, Llp$3.86M
Related GALT Institutional Insights:
- GALT 13F Institutional Holders
- GALT Superinvestors
- GALT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GALT Insider Trading & SEC Form 4 Activity
- GALT Articles
- Top Institutional Investor Stock Rankings